Activation of the CD95 (APO-1/Fas) pathway in drug- and γ-irradiation-induced apoptosis of brain tumor cells

Cell Death and Differentiation

Volumn 5, Issue 10, 1998, Pages 884-893

  Fulda, Simone ^a   Scaffidi, Carsten ^b   Pietsch, Torsten ^c   Krammer, Peter H ^b   Peter, Marcus E ^b   Debatin, Klaus Michael ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Apoptosis; Brain tumors; CD95 (APO 1 Fas); Drugs; irradiation

Indexed keywords

ANTIINFECTIVE AGENT; CESIUM 137; CISPLATIN; DOXORUBICIN; FAS ANTIGEN; INTERLEUKIN 1; PROTEINASE INHIBITOR;

ANTIGEN ANTIBODY REACTION; APOPTOSIS; ARTICLE; BRAIN TUMOR; CHEMOSENSITIVITY; CROSS LINKING; GLIOBLASTOMA; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; PRIORITY JOURNAL; SOLID TUMOR;

EID: 0031762951     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400419     Document Type: Article

References (50)

1. Cote RJ, Esrig D, Groshen S, Jones PA and Skinner DG (1997) p53 and treatment of bladder cancer. Nature 385: 123-125
2. Datta R, Kojima H, Banach D, Bump NJ, Talanian RV, Alnemri ES, Weichselbaum RR, Wong WW and Kufe DW (1997) Activation of a CrmA-insensitive. p53-sensitive pathway in ionizing radiation-induced apoptosis. J Biol Chem. 272: 1965-1969
3. Debatin KM (1996) Disturbances of the CD95 (APO-1/Fas) system in disorders of lymphohaematopoietic cells Cell Death Differ. 3: 185-189
4. Debatin KM (1997) Cytotoxic drugs, cell death and the immune system defining new roles in an old play J. Natl. Cancer Inst. 89: 750-751
5. Deen DF, Chiarodo A, Grimm EA, Fike JR, Israel MA, Kun LE, Levin VA, Marton LJ, Packer RJ and Pegg AE (1993) Brain tumor working group report on the 9th international conference on brain tumor research and therapy. J Neurooncol.16: 243-272
6. Dhein J, Walczak H, Baeumler C, Debatin KM and Krammer PH (1995) AutocrineT-cell suicide mediated by APO-1 (Fas/CD95). Nature 373: 438-441
7. Dominici C, Petrucci F, Caroli S, Alimonti A, Clenco A and Castello MA (1989) A , pharmacokinetic study of high-dose continuous infusion cisplatin in children with solid tumors. J. Clin Oncol. 7: 100-107
8. Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ and Kaufmann SH (1997) Companson of apoptosis in wild-type and Fasresistant cells, chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood 90: 935-943
9. Fisher DE (1994) Apoptosis in cancer therapy crossing the threshold. Cell 78: 539-542
10. Friedman HS, Oakes WJ, Bigner SH, Wikstrand CJ and Bigner DD (1991) Medulloblastoma. tumor biological and clinical perspectives J. Neurooncol. 11. 1-15
11. Friedman HS, Burger PC, Bigner SH, Trojanowski JQ, Wikstrand CJ, Halperin EC and Bigner DD (1985) Establishment and characterization of the human medulloblastoma cell line and transplantable xenograft D283. Med. J. Neuropatnol Exp.Neurol. 44: 592-605
12. Friesen C, Herr I, Krammer PH and Debatin KM (1996) Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells Nat Med. 2: 574-577
13. Fulda S, Sieverts H, Friesen C, Herr I and Debatin KM (1997) The CD95 (APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res. 57: 3823-3829
14. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H and Parks W (1973) In vitro cultivation of human tumors, establishment of cell lines derived from a series of solid tumors J. Natl Cancer Inst 51. 1417-1421
15. Haas-Kogan DA, Yount G, Haas M, Levi D, Kogan SS, Hu L, Vidair C, Deen DF, Dewey WC and Israel MA (1996) p53-dependent G1 arrest and p53-independent apoptosis influence the radiobiologic response of glioblastoma. Int. J. Radiat Oncol. Biol. Phys. 36. 95-103
16. Jacobsen PF, Jenkyn DJ and Papadimitriou JM (1985) Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice J. Neuropathol. Exp. Neurol 44 472-485
17. Kaufmann SH, Desnoyers S, Ottaviano Y, Davidson NE and Poirier GG (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis Cancer Res. 53. 3976-3985
18. Kischkel FC, Hellbardt S, Behrmann I, Germer M, Pawlita M, Krammer PH and Peter ME (1995) Cytotoxicity-dependentAPO-1 (Fas/CD95)-associated proteins form a death-inducing signaling complex (DISC) with the receptor. EMBO J. 14: 5579-5588
19. Kondo S, Barna BP, Morimura T, Takeuchi J, Yuan J, Akbasak A and Barnett GH (1995) Interleukin-1 β-converting enzyme mediates cisplatin-induced apoptosis in malignant glioma cells Cancer Res. 55: 6165-6171
20. Krammer PH, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Fath M, Daniel PT, Knipping E, Westendorp MO and Debatin KM (1994) The role of APO-1-mediated apoptosis in the immune system Immunol. Rev. 142: 175-191
21. LiebermanN DA, Huffman B and Steinman RA (1995) Molecular controls of growth arrest and apoptosis: p53-dependent and independent pathways. Oncogene 11: 199-210
22. Los M, Herr I, Friesen C, Fulda S, Schulze-Osthoff K and Debatin KM (1997) Crossresistance of CD95- and drug-induced apoptosis as a consequence of deficient activation of caspases (ICE/Ced-3 proteases). Blood 90: 3118-3129
23. Los M, Van de Craen M, Penning LC, Schenk H, Westendorp M, Baeuerle P, Droge W, Krammer PH, Fiers W and Schulze-Osthoff K (1995) Requirement of an ICE/ Ced-3 protease for Fas/APO-1 -mediated apoptosis Nature 375: 81-83
24. Lowe SW, Ruley HE, Jacks T and Housman DE (1993) p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74: 957-967
25. Matusomoto H, Shimura M, Omatsu T, Okaichi K, Majima H and Ohnishi (1994) T p53 proteins accumulated by heat stress associate with heat shock proteins HSP72/ HSC73 in human glioblastoma cell lines Cancer Lett. 87 39-46
26. Medema JP, Scaffidi C, Kischkel FC, Shevchenko A, Mann M, Krammer PH and Peter ME (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16: 2794-2804
27. Meyn RE, Stephens LC and Milas L (1996) Programmed cell death and radioresistance. Cancer Metastasis Rev. 15. 119-131
28. Michaeu O, Solary E, Hammann A, Martin F and Dimanche-Boitrel MT (1997) Sensitization of cancer cells treated with cytotoxic drugs to Fas-mediated cytotoxicity. J. Natl Cancer Inst 89: 783-789
29. Muller C, Chatelut E, Gualano V, De Forni M, Huguet F, Attal M, Canal P and Laurent G (1993) Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion. Cancer Chemother. Pharmacol 32: 379-384
30. Mueller M, Strand S, Hug H, Heinemann EM, Walczak H, Hofmann WJ, Stremmel W, Krammer PH and Galle PR (1997) Drug-induced apoptosis in hepatoma cells is mediated by the CD95 (APO-1/Fas) receptor/ligand) system and involves activation of wild-type p53. J. Clin. Invest. 99: 403-413
31. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter ME and Dixit VM (1996) FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex Cell 85: 817-827
32. Nagata S (1997) Apoptosis by death factor. Cell 88: 355-365
33. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F and Riccardi C (1991) A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and low cytometry J. Immunol. Methods 139: 271-279
34. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li Weber M, Richards S, , Dhein J, Trauth BC, Ponstingl H and Krammer PH (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. J. Biol Chem 257: 10709-10715
35. Owen-Schaub LB Zhang W, Cusack JC, Angelo LS, Santee SM, Fujiwara T, Roth JA, Deisseroth AB, Zhang WW, Kruzel E and Radinsky R (1995) Wild-type human p53 and a temperature-sensitive mutant induce Fas/APO-1 expression. Mol. Cell Biol 15: 3032-3040
36. Peter ME, Kischkel FC, Hellbardt S, Chinnaiyan AM, Krammer PH and Dixit VM (1996) CD95 (APO-1/Fas)-associating signaling proteins Cell Death Differ. 3. 161-170
37. Pollack IF, Hamilton RL, Finkelstein SD, Campell JW, Martinez AJ, Sherwin RN, Bozik ME and Gollin SM (1997) The relationship between tp53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood. Cancer Res. 57: 304-309
38. Reap EA, Roof K, Maynor K, Borrero M, Booker J and Cohen PL (1997) Radiation and stress-induced apoptosis: a role for Fas/Fas ligand interaction. Proc. Natl. Acad. Sci. USA 94. 3750-3755
39. Saylors RL, Sidransky D, Friedman HS, Bigner SH, Bigner DD, Vogelstein B and Brodeur GM (1991) Infrequent p53 gene mutations in medulloblastoma Cancer Res 51: 4721-4723
40. Scaffidi C, Medema JP, Krammer PH and Peter ME (1997) FLlCE is predominantly expressed as two functionally active isoforms, caspase-8/a and caspase-3/b. J. Biol. Chem 272: 26953-26958
41. Stevens MC, Cameron AH, Muir KR, Parkes SE, Reid H and Whitwell H (1991) Descriptive epidemiology of primary central nervous system tumors in children: a population-based study. Clin Oncol R. Coll. Radiol. 3: 323-329.
42. Suda T, Takahashi T, Golstein P and Nagata S (1993) Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75: 1169-1178
43. Tanaka M, Suda T, Takahashi T and Nagata S (1995) Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14: 1129-1135
44. Tewan M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS and Dixit VM (1995) Yama/CPP32β, a mammalian homolog of Ced-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell 81: 801-809
45. Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462
46. Trauth BC, Klas C, Peter AM, Matzku S, Moeller P, Falk W, Debatin KM and Krammer PH (1989) Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245: 301-305
47. Villunger A, Egle A, Kos M, Hartmann BL, Geley S, Kofler R and Greil R (1997) Drug-induced apoptosis is associated with enhanced Fas (APO-1/CD95) ligand expression but occurs independently of Fas (APO-1/CD95) signaling in human T-cute lymphatic leukemia cells Cancer Res. 57: 3331-3334
48. Wahl AF, Donaldson KL, Fairchild C, Lee FY, Foster SA, Demers GW and Galloway DA (1996) Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis. Nat. Med 2:72-79
49. Weller M, Malipiero U, Aguzzi A, Reed JC and Fontana A (1995) Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apopiosis of human malignant glioma cells and confers resistance to chemotherapeutic drugs and therapeutic irradiation. J. Clin. Invest. 95: 2633-2643
50. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y and Fontana A (1994) Anti-Fas/APO-1 antibody mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J. Clin. Invest 94: 954-964